central vaccine (072020) has 8 disclosed insider purchases and 1 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩465M ($323K) in reported transaction value. The earliest filing StockDrifts holds for central vaccine is dated 2021-05-31; the most recent is 2026-06-10. Across these filings the average return since disclosure is -9.74%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-08-01 | BUY | Market Buy | 신영학 Younghak Shin | moving | 2.2K | ₩9,200 | +1.0% | ₩20M ($14K) |
| 2026-06-10 | BUY | Market Buy | 윤인중 Yoon In-joong | CEO | 11.0K | - | - | - |
| 2026-04-28 | BUY | Market Buy | 김은희 Eunhee Kim | Managing Director | 6.2K | ₩9,870 | +2.7% | ₩61M ($42K) |
| 2026-04-27 | BUY | Market Buy | 김은희 Eunhee Kim | Managing Director | 24.8K | ₩9,810 | +3.4% | ₩244M ($169K) |
| 2026-04-27 | BUY | Market Buy | 윤석인 Seokin Yoon | Each CEO | 3.3K | ₩9,810 | +3.4% | ₩32M ($22K) |
| 2026-04-24 | BUY | Market Buy | 윤석인 Seokin Yoon | Each CEO | 10.3K | ₩9,830 | +3.1% | ₩101M ($70K) |
| 2025-01-01 | BUY | 신규선임 | 윤석인 Seokin Yoon | moving | 717.2K | ₩9,850 | -1.0% | ₩7.1B ($4.9M) |
| 2024-11-01 | SELL | Market Sell | 최환원 Choi Hwan-won | Managing Director | -2.6K | ₩10,590 | +7.9% | ₩27M ($19K) |
| 2022-09-23 | BUY | Market Buy | 최환원 Choi Hwan-won | Managing Director | 1 | ₩11,550 | -15.6% | ₩12K ($8) |
| 2021-08-19 | BUY | Market Buy | 최환원 Choi Hwan-won | Managing Director | 2 | ₩15,750 | -38.1% | ₩32K ($22) |
| 2021-05-31 | BUY | Market Buy | 최환원 Choi Hwan-won | Managing Director | 2 | ₩17,650 | -44.8% | ₩35K ($25) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.